UBS today maintained a Sell rating on Edwards Lifesciences (NYSE: EW) and lowered its price target to $64.00 (from $82) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

StreetInsider.com Pre-Open Movers 4/24: (BKI) (IRBT) (YUM) Higher; (VOCS) (EW) (AAPL) Lower (more...)April 24, 2013 9:36 AM RBC Capital Downgrades Edwards Lifesciences (EW) to Sector PerformApril 24, 2013 6:47 AM Lazard Capital Downgrades Edwards Lifesciences (EW) to NeutralApril 24, 2013 6:46 AM Edwards Lifesciences Corp. (EW) Misses Q1 EPS by 4c, Lowers GuidanceApril 23, 2013 4:17 PM